论文部分内容阅读
既不像辉瑞那样“功利”,又不像默沙东那样理想化,诺华似乎找到了一条理想的中间道路
Neither is it “utilitarian” like Pfizer, nor idealized by Merck, Novartis seems to have found an ideal middle way